![Nerissa Kreher](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nerissa Kreher
Direttore/Membro del Consiglio presso REZOLUTE, INC.
Patrimonio netto: 570 527 $ in data 30/06/2024
Posizioni attive di Nerissa Kreher
Società | Posizione | Inizio | Fine |
---|---|---|---|
REZOLUTE, INC. | Direttore/Membro del Consiglio | 02/03/2021 | - |
Independent Dir/Board Member | 02/03/2021 | - |
Storia della carriera di Nerissa Kreher
Precedenti posizioni note di Nerissa Kreher
Società | Posizione | Inizio | Fine |
---|---|---|---|
ENTRADA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/12/2020 | 01/02/2024 |
Tiburio Therapeutics, Inc.
![]() Tiburio Therapeutics, Inc. BiotechnologyHealth Technology Tiburio Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It provides novel treatments for rare neuroendocrine tumors and endocrine diseases. The company was founded by James Gregg McArthur in January 2019 and is headquartered in Cambridge, MA. | Direttore Tecnico/Scientifico/R&S | 01/02/2019 | 01/10/2020 |
TECTONIC THERAPEUTIC, INC. | Direttore Tecnico/Scientifico/R&S | 17/12/2018 | 17/12/2018 |
LARIMAR THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/03/2015 | 01/07/2016 |
Shire Human Genetic Therapies, Inc.
![]() Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Direttore Tecnico/Scientifico/R&S | - | - |
EMD Serono, Inc.
![]() EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Direttore Tecnico/Scientifico/R&S | - | - |
ALEXION PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Nerissa Kreher
The University of North Carolina at Charlotte | Undergraduate Degree |
East Carolina University | Doctorate Degree |
Indiana University | Graduate Degree |
Northeastern University | Masters Business Admin |
The University of North Carolina at Chapel Hill | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 14 |
Posizioni
Chief Tech/Sci/R&D Officer | 7 |
Undergraduate Degree | 2 |
Doctorate Degree | 1 |
Settori
Health Technology | 9 |
Consumer Services | 6 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
REZOLUTE, INC. | Health Technology |
ENTRADA THERAPEUTICS, INC. | Health Technology |
Aziende private | 6 |
---|---|
Zafgen, Inc.
![]() Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
Avrobio, Inc.
![]() Avrobio, Inc. BiotechnologyHealth Technology AVROBIO, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. The firm's clinical-stage programs include Fabry, Gaucher Type 1, Hunter syndrome Gaucher Type 3, Pompe, and Cystinosis. The company was founded by Geoff Mackay, Kim Warren, Christopher Mason, and Jeffrey Medin in 2015 and is headquartered in Watertown, MA. | Health Technology |
Tiburio Therapeutics, Inc.
![]() Tiburio Therapeutics, Inc. BiotechnologyHealth Technology Tiburio Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It provides novel treatments for rare neuroendocrine tumors and endocrine diseases. The company was founded by James Gregg McArthur in January 2019 and is headquartered in Cambridge, MA. | Health Technology |
Alexion Pharmaceuticals, Inc.
![]() Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
EMD Serono, Inc.
![]() EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Shire Human Genetic Therapies, Inc.
![]() Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Health Technology |
- Borsa valori
- Insiders
- Nerissa Kreher
- Esperienza